Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Rosacea
ADR ID BADD_A03896
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.08      Rosaceas
23.02.08.001      Rosacea
Description A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7). | A variant of rosacea. [MeSH]
MedDRA Code 10039218
MeSH ID D012393; D012393; D012393
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acne rosacea | Rosacea | Rosacea-like dermatitis | Rosacea aggravated | Acne Rosacea | Phymatous Rosacea | Rosacea, Phymatous | Ocular Rosacea | Rosacea, Ocular | Papulopustular Rosacea | Rosacea, Papulopustular | Erythematotelangiectatic Rosacea | Rosacea, Erythematotelangiectatic | Granulomatous Rosacea | Rosacea, Granulomatous
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.001212%
BADD_D00156Apremilast0.003474%
BADD_D00165Aripiprazole--
BADD_D00294Brimonidine0.005753%
BADD_D00349Capecitabine--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00490Clobetasol propionate--
BADD_D00491Clobetasone butyrate--
BADD_D00580Dapsone0.001603%
BADD_D00680Dimethyl fumarate0.002751%
BADD_D00720Doxepin--
BADD_D00751Eflornithine--
BADD_D00752Eflornithine hydrochloride--
BADD_D00800Erlotinib0.000533%
BADD_D00856Etoricoxib--
BADD_D00858Everolimus0.000730%
BADD_D00898Finasteride0.000855%
BADD_D01088Hydrocortisone butyrate--
BADD_D01221Ivermectin0.035557%
BADD_D01250Lasofoxifene--
BADD_D01253Lenalidomide--
BADD_D01281Levonorgestrel0.007296%
BADD_D01300Lisinopril0.000021%
BADD_D01418Methotrexate0.000560%
BADD_D01449Metronidazole0.000417%
BADD_D01470Minocycline0.000777%
BADD_D01490Mometasone--
BADD_D01491Mometasone furoate--
BADD_D01567Nilotinib0.000799%
The 1th Page    1 2    Next   Last    Total 2 Pages